Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Juan Pablo Frias, MD
Biomea Fusion Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. T.G Elliott Inc. Dba Bc Diabetes
Vancouver, British Columbia, Canada
- Centricity Research
Toronto, Ontario, Canada
- Oceanic Research Group
North Miami Beach, Florida, United States
- Lucas Research, Inc.
Morehead City, North Carolina, United States
- Alliance for Multispecialty Research, Llc.
Norman, Oklahoma, United States
- University Diabetes & Endocrine Consultants
Chattanooga, Tennessee, United States
- Velocity Clinical Research
Dallas, Texas, United States
- Texas Diabetes & Endocrinology
Round Rock, Texas, United States
- Diabetes & Glandular Disease Clinic, P.A.
San Antonio, Texas, United States
- Consano Clinical Research, Llc
Shavano Park, Texas, United States
- Manassas Clinical Research Center
Manassas, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Dec 2023
- Primary completion
- 20 May 2025
- Completion
- 18 Jul 2025
- Last update posted
- 14 May 2026
- Registered enrollment
- 37
- Registry id
- NCT06152042
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.